A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53427

language	eng
Author	Inoue Satoshi Clinical Development Department, R&D Division, Daiichi Sankyo, Tokyo SAITO, Yoji Tsuneto Satoru Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto Aruga Etsuko Department of Palliative Medicine, School of Medicine, Teikyo University, Tokyo Ide Azusa Clinical Development Department, R&D Division, Daiichi Sankyo Kakurai Yasuyuki Biostatistics and Data Management Department, R&D Division, Daiichi Sankyo, Tokyo, Japan
Subject	hydromorphone; oxycodone; cancer pain; palliative medicine; double-blind study
Journal Title	JOURNAL OF PAIN RESEARCH
Volume	10
Start Page	1953
End Page	1961
ISSN	1178-7090
Published Date	2017
DOI	10.2147/JPR.S136937
PubMed ID	28860850
Publisher	DOVE MEDICAL PRESS LTD
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	This study and preparation of this report were funded by Daiichi Sankyo Co Ltd. The authors wish to thank all of the investigators at the participating centers (see Box S1) for their contribution to this study. We would also like to thank Marion Barnett of Edanz Medical Writing for providing editorial support.